RE:are they targeting Pfizer?Per the previous post, many pharma companies (sans Biogen) have more cash on hand in 2020 than in previous years, in many cases as of 30 SEP 2020 (post COVID).
To me, that is the biggest 'external factor', and it does not really align with the update from PMN citing external factors.
I guess I am trying to say that the update and playing the COVID card with respect to PMN310 captial raise is not sitting well with me.